Central Pharmaceutical Joint Stock Company No3 reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was VND 108,225.41 million compared to VND 80,924.87 million a year ago. Net income was VND 16,289.52 million compared to VND 13,358.16 million a year ago. Basic earnings per share from continuing operations was VND 757.6 compared to VND 621.2 a year ago.
For the nine months, revenue was VND 359,553.45 million compared to VND 273,898.1 million a year ago. Net income was VND 68,078.35 million compared to VND 62,234.54 million a year ago. Basic earnings per share from continuing operations was VND 3,166.4 compared to VND 2,894.8 a year ago.